论文部分内容阅读
近几年来,我们用蝮蛇抗栓酶治疗闭塞性血管疾病129例,哮喘病1例,出现不良反应共5例(不包括正常反应)。其中用沈阳第一制药厂生产的江浙蝮蛇抗检酶(Ⅰ)静滴治疗50例,出现不良反应2例;用深圳长白山制药厂生产的蝮蛇抗栓酶(Ⅱ)静滴治疗17例,有不良反应2例;中国医科大学老年病防治研究中心生产的抗栓酶-3(Ⅲ)静滴治疗63例,有不良反应1例。详见附表。
In recent years, we use viper antithrombin treatment of occlusive vascular disease in 129 cases, 1 case of asthma, there were 5 cases of adverse reactions (not including the normal reaction). Among them, 50 cases were treated with intravenous infusion of Jiangsu snake snake antiseptics (Ⅰ) produced by Shenyang No.1 Pharmaceutical Factory, and 2 cases appeared adverse reactions; 17 cases were treated by intravenous infusion of viper antithrombin (Ⅱ) produced by Changbai Mountain Pharmaceutical Factory in Shenzhen , There were 2 adverse reactions; 63 cases of Antithrombin-3 (Ⅲ) intravenous infusion produced by the Research Center for Geriatrics Control of China Medical University were treated with adverse reactions in 1 case. See schedule.